Jennifer A. Jarrett
Independent DirectorMs. Jennifer A. Jarrett, also known as Jen, M.B.A. is President, CEO and Director at Damora Therapeutics, Inc. from March 30, 2026. She serves as a Director at LifeMine Therapeutics, Inc. from October 2022. She serves as Director at Cajal Neuroscience, Inc. She is Independent Director of Sagimet Biosciences Inc. from August 1, 2024. She is an accomplished executive in the healthcare and technology industries with expertise spanning operations, capital markets, finance, corporate development and strategy. She served as an Independent Director at Radius Health, Inc. since May 20, 2022 until August 10, 2022. She serves as Independent Director at Zura Bio Limited since March 21, 2023. She had been Non-Employee Director of Arcus Biosciences, Inc. since January 12, 2019 until January 2024 and was its Chief Operating Officer since October 1, 2020 until March 30, 2026. She serves as Independent Director at Consonance-HFW Acquisition Corp since 2020. Ms. Jarrett served as a Vice President of Corporate Development and Capital Markets at Uber Technologies, Inc. from January 2019 to September 2020. She served as Chief Operating Officer of Arcus Biosciences, Inc. since June 12, 2018 until January 11, 2019 and served as its Chief Financial Officer since March 2017 until January 11, 2019. Ms. Jarrett served as Chief Business of Arcus Biosciences, Inc. since March 2017 until June 12, 2018. Ms. Jarrett holds experience in investment banking. She served as the Chief Financial Officer of Medivation, Inc. from April 7, 2016 to September 28, 2016. She was Chief Business Officer and Chief Financial Officer from March 2017 to June 2018. She was responsible for finance, accounting, information technology, Investor Relations, strategy and business development. She served as Managing Director at Citigroup from July 2010 to April 2016, where she was responsible for building and managing Citigroup's West Coast life sciences and biotechnology investment banking group. She served as a Managing Director of Health Care Group at Credit Suisse from 2000 to 2010, where she focused on the biotechnology sector. From 1998 to 2000, she was at Donaldson, Lufkin & Jenrette until it was acquired by Credit Suisse. She is an Independent Director at Syndax Pharmaceuticals, Inc. since September 25, 2018. Prior to Citigroup, Ms. Jarrett worked in the investment banking divisions of Merrill Lynch and Kidder Peabody. During her tenure as an investment banker, Ms. Jarrett covered biotechnology and pharmaceutical companies, primarily in the San Francisco Bay Area. She is an accomplished Life Sciences Industry Leader, who has built value through her successful roles in investment banking and industry. She had been a Director of Arena Pharmaceuticals, Inc. since June 14, 2017 until its acquisition by Pfizer in March 11, 2022. She served as a Director of Audentes Therapeutics, Inc. from June 13, 2017 to January 15, 2020. She is on the Board of The Clearity Foundation, a non-profit organization focused on improving treatment options for ovarian cancer patients. She has extensive experience in the life science industry and financial management of life science companies. Ms. Jarrett earned a Bachelor of Arts in Economics, cum laude, from Dartmouth College and holds a Master of Business Administration from Stanford University Graduate School of Business.
Positions
- Company NameSyndax Pharmaceuticals, Inc.Stock CodeSNDXPositionIndependent DirectorColleagues
- MAMichael A. MetzgerCEO & Director
- DGDennis G. PodlesakIndependent Chairman
- LJLuke J. AlbrechtGeneral Counsel & Corporate Secretary
- KAKeith Alan GoldanExecutive Officer
- SCSteven ClosterChief Commercial Officer
- NANicholas A.J. BotwoodHead of Research & Development and Chief Medical Officer
- PLPierre LegaultIndependent Director
- KAKeith A. KatkinIndependent Director
- JAJennifer A. JarrettIndependent Director
- Company NameDamora Therapeutics, Inc.Stock CodeDMRAPositionCEO, President & DirectorColleagues
- GWGarrett WinslowSenior VP, General Counsel & Corporate Secretary
- PEPeter Evan HarwinIndependent Chairman of the Board
- UJUlf J. NilssonCo-Founder
- HLHakon LefflerCo-Founder
- TSTariq SethiCo-Founder
- CWChristopher W. CainIndependent Director
- MLMichael LandsittelIndependent Director
- JFJonathan FallowfieldMember of Clinical Advisory Board – Liver cirrhosis
